Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: ACC

ANNUAL REPORT 2023 ZINZINO AB (PUBL)


GOTHENBURG, Sweden, April 26, 2024 /PRNewswire/ -- Zinzino (publ) announces that the company's annual report for 2023 in Swedish is now published on the company's website, zinzino.com. The English version will be published within approximately 45 days.

The 2024 Annual General Meeting will be held at the company's premises at Hulda Mellgrens gata 5 in Västra Frölunda on May 27 at 1:30 p.m. The nomination committee's proposals for board members, the board's remuneration and auditors are presented in the notice to the annual general meeting. For further information about the annual general meeting, refer to the company's website www.zinzino.com.

Link to the report:

https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/

For more information please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, email: [email protected]
Fredrik Nielsen CFO Zinzino +46 707 900 174, email: [email protected]

Images for free publication:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/annual-report-2023-zinzino-ab--publ-,c3968373

The following files are available for download:

https://mb.cision.com/Public/10976/3968373/99f22d1279aa00b7.pdf

Press Release Zinzio Annual Report 2023

 


These press releases may also interest you

at 06:15
Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"
Representatives from the Mario Lemieux Foundation and Highmark Health today announced a major collaborative gift to Allegheny Health Network's (AHN) Cardiovascular Institute that will further strengthen the organization's...

at 06:05
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced longer-term data updates from its lentiviral (LV)...

at 06:00
Medical Polymer Market worth $60.5 billion by 2029 - Exclusive Report by MarketsandMarketstm
The report "Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global...

at 06:00
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration
Next-generation gene therapy demonstrates best-in-class potential with majority of neurons transduced in substantia nigra and high levels of GCase supplementation after single IV infusion Broad GCase elevation achieved in NHPs, while significantly...

at 06:00
Celebrate Women During Women's Health Week with Women's Excellence
As we head into Women's Health Week, Women's Excellence is proud to reaffirm its dedication to the well-being and empowerment of women across Metro Detroit. From May 12th to May 18th, our practice joins the nationwide effort to highlight the...

at 06:00
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell Therapy 2024 Annual Meeting
...

More news about Health...


News published on and distributed by: